High‐density lipoprotein apolipoprotein A‐I kinetics: comparison of radioactive and stable isotope studies
- 9 August 2006
- journal article
- Published by Wiley in European Journal of Clinical Investigation
- Vol. 36 (9) , 626-632
- https://doi.org/10.1111/j.1365-2362.2006.01708.x
Abstract
Background To compare the kinetic determinants of high‐density lipoprotein (HDL) apolipoprotein A‐I (apoA‐I) concentration in lean normolipidaemic subjects using radioisotope and stable isotope studies. Materials and methods We pooled data from 16 radioisotope and 13 stable isotope studies to investigate the kinetics of apoA‐I in lean normolipidemic individuals. We also examined the associations of HDL kinetic parameters with age, sex, body mass index (BMI) and concentrations of apoA‐I, triglycerides, HDL cholesterol and low‐density lipoprotein (LDL) cholesterol. Results Lean subjects from radioisotope and stable isotope studies were matched for age, gender, BMI and lipid profile. The apoA‐I concentration was significantly lower in the radioisotope group than the stable isotope group (P = 0·031). There was no significant difference in HDL apoA‐I fractional catabolic rate (FCR) and production rate (PR) between the groups. In the radioisotope group, HDL apoA‐I FCR was significantly associated with apoA‐I and HDL cholesterol concentrations (r = −0·681, P < 0·001 and r = −0·542, P < 0·001, respectively), whereas in the stable isotope group, only HDL apoA‐I PR was significantly associated with apoA‐I concentration (r = 0·455, P = 0·004). Conclusions Our findings suggest that HDL apoA‐I FCR is the primary determinant of apoA‐I concentrations in lean subjects in studies using radiotracer techniques. By contrast, HDL apoA‐I PR is the primary determinant of apoA‐I concentration in lean subject in studies employing stable isotope methods. These discrepancies may be reconciled by differences in methodologies and/or study population characteristics.Keywords
This publication has 42 references indexed in Scilit:
- Lipoprotein transport in the metabolic syndrome: methodological aspects of stable isotope kinetic studiesClinical Science, 2004
- Lipoprotein Metabolism in Obesity and Diabetes: Insights from Stable Isotope Kinetic Studies in HumansNutrition Reviews, 2003
- Plasma turnover of HDL apoC-I, apoC-III, and apoE in humansJournal of Lipid Research, 2003
- Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle‐aged menAnnals of Human Genetics, 2002
- Effect of dietary omega-3 fatty acids on high-density lipoprotein apolipoprotein AI kinetics in type II diabetes mellitusAtherosclerosis, 2001
- In Vivo Evidence for the Role of Lipoprotein Lipase Activity in the Regulation of Apolipoprotein AI Metabolism: A Kinetic Study in Control Subjects and Patients with Type II Diabetes MellitusJournal of Clinical Endocrinology & Metabolism, 2001
- Increased Production of HDL ApoA-I in Homozygous Familial Defective ApoB-100Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Subjects With ApoA-I(Lys 107 →0) Exhibit Enhanced Fractional Catabolic Rate of ApoA-I in Lp(AI) and ApoA-II in Lp(AI With AII)Arteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Metabolism of apolipoproteins A-I and A-ll and its influence on the high density lipoprotein subfraction distribution in males and femalesEuropean Journal of Clinical Investigation, 1978
- High Density Lipoprotein Metabolism in ManJournal of Clinical Investigation, 1977